Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Initial patterns of use of COX-2 inhibitors by elderly patients in Ontario: findings and implications.

× No keyword cloud information.

2 in total

1. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

Authors: F E Silverstein; G Faich; J L Goldstein; L S Simon; T Pincus; A Whelton; R Makuch; G Eisen; N M Agrawal; W F Stenson; A M Burr; W W Zhao; J D Kent; J B Lefkowith; K M Verburg; G S Geis
Journal: JAMA Date: 2000-09-13 Impact factor: 56.272

2. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

Authors: C Bombardier; L Laine; A Reicin; D Shapiro; R Burgos-Vargas; B Davis; R Day; M B Ferraz; C J Hawkey; M C Hochberg; T K Kvien; T J Schnitzer
Journal: N Engl J Med Date: 2000-11-23 Impact factor: 91.245

2 in total

10 in total

1. Why don't we initiate more large simple randomized controlled trials?

Authors: James M Wright
Journal: CMAJ Date: 2003-11-25 Impact factor: 8.262

Review 2. Oral cyclo-oxygenase 2 inhibitors versus other oral analgesics for acute soft tissue injury: systematic review and meta-analysis.

Authors: Peter Jones; Rain Lamdin
Journal: Clin Drug Investig Date: 2010 Impact factor: 2.859

3. Changes in rates of upper gastrointestinal hemorrhage after the introduction of cyclooxygenase-2 inhibitors in British Columbia and Ontario.

Authors: Muhammad Mamdani; Leanne Warren; Alex Kopp; J Michael Paterson; Andreas Laupacis; Ken Bassett; Geoffrey M Anderson
Journal: CMAJ Date: 2006-12-05 Impact factor: 8.262

4. What influences seniors' choice of medications for osteoarthritis? Qualitative inquiry.

Authors: Kelly Nicol Bower; Dawn Frail; Peter L Twohig; Wayne Putnam
Journal: Can Fam Physician Date: 2006-03 Impact factor: 3.275

5. Managing osteoarthritis. Medication use among seniors in the community.

Authors: Beverley Lawson; Wayne Putnam; Kelly Nicol; Greg Archibald; Jim Mackillop; Howard Conter; Dawn Frail
Journal: Can Fam Physician Date: 2004-12 Impact factor: 3.275

6. Outcome trials of COX-2 selective inhibitors: global safety evaluation does not promise benefits.

Authors: Jorge Gomez Cerezo; Rubin Lubomirov Hristov; Antonio J Carcas Sansuán; Juan J Vázquez Rodríguez
Journal: Eur J Clin Pharmacol Date: 2003-04-16 Impact factor: 2.953

7. Is There a Tension between Clinical Practice and Reimbursement Policy? The Case of Osteoarthritis Prescribing Practices in Ontario.

Authors: Parminder S Raina; Amiram Gafni; Sandra Bell; Susan Grant; Rolf J Sebaldt; Aimei Fan; Annie Petrie; Kevin Skilton
Journal: Healthc Policy Date: 2007-11

Review 8. A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity.

Authors: Philip G Conaghan
Journal: Rheumatol Int Date: 2011-12-23 Impact factor: 2.631

Review 9. Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data.

Authors: Michèle Bally; Nandini Dendukuri; Benjamin Rich; Lyne Nadeau; Arja Helin-Salmivaara; Edeltraut Garbe; James M Brophy
Journal: BMJ Date: 2017-05-09

10. Encouraging physician appropriate prescribing of non-steroidal anti-inflammatory therapies: protocol of a randomized controlled trial [ISRCTN43532635].

Authors: Malcolm Doupe; Alan Katz; Brent Kvern; Lori-Jean Manness; Colleen Metge; Glen T D Thomson; Laura Morrison; Kat Rother
Journal: BMC Health Serv Res Date: 2004-08-24 Impact factor: 2.655

10 in total